— Know what they know.
Not Investment Advice

NEUP NASDAQ

Neuphoria Therapeutics Inc.
1W: -4.9% 1M: -7.5% 3M: +0.9% YTD: -9.2% 1Y: -75.0% 3Y: -70.6%
$3.47
-0.04 (-1.14%)
 
Weekly Expected Move ±2.0%
$3 $3 $3 $4 $4
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 32 · $18.8M mcap · 4M float · 3.47% daily turnover · Short 41% of daily vol

Supply Chain Overview

3 relationships
3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2024-10-02
Earliest Filing
2024-11-21
Latest Filing
partner: 2 acquirer: 1

Counterparties (Filed by NEUP)

3 relationships

Companies named in NEUP's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
H.C. Wainwright & Co., LLC — partner Sales Agent for the At The Market Offering Agreement 2024-11-21 View
Cantor Fitzgerald & Co. — partner Previous ATM Agent for the terminated offering program 2024-11-21 View
Neuphoria Therapeutics Inc. NEUP acquirer Acquiring Bionomics Limited via a Scheme Implementation Agreement to re-domicile Bionomics as a wholly-owned subsidiary. 2024-10-02 View
Recent 8-K Filings (19)
Filing Date Description Type SEC
2026-07-24 Material Agreement; Change in Control; Regulation FD; Exhibits Agreement View
2026-05-26 Other Events View
2026-01-08 Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Financial St Agreement View
2025-12-18 Notice of Delisting or Transfer View
2025-12-17 Submission of Matters to a Vote of Security Holders View
2025-10-27 Entry into Material Definitive Agreement; Material Modification to Rights of Security Holders; Amend Agreement View
2025-10-20 Other Events; Financial Statements and Exhibits View
2025-09-16 Notice of Delisting or Transfer; Financial Statements and Exhibits View
2025-07-18 Notice of Delisting or Transfer; Financial Statements and Exhibits View
2025-05-20 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-01-14 Other Events View
2024-12-23 Entry into Material Definitive Agreement; Notice of Delisting or Transfer; Unregistered Sales of Equ Agreement View
2024-12-16 Other Events; Financial Statements and Exhibits View
2024-12-12 Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits View
2024-11-21 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2024-11-08 Other Events; Financial Statements and Exhibits View
2024-10-10 Departure/Election of Directors; Appointment of Officers View
2024-10-02 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2024-07-16 Notice of Delisting or Transfer View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms